Compare Stocks

Date Range: 

 Merck & Co., Inc.NovartisAbbVieEli Lilly andPfizer
SymbolNYSE:MRKNYSE:NVSNYSE:ABBVNYSE:LLYNYSE:PFE
Price Information
Current Price$77.96$87.30$115.12$194.76$39.70
52 Week RangeBuyHoldBuyBuyHold
MarketRank™
Overall Score2.22.02.72.12.1
Analysis Score2.43.21.42.42.1
Community Score2.52.32.92.82.9
Dividend Score2.52.55.02.52.5
Ownership Score1.70.01.71.71.7
Earnings & Valuation Score1.91.92.51.31.3
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$97.50$108.50$117.13$200.75$39.64
% Upside from Price Target25.06% upside24.28% upside1.74% upside3.08% upside-0.14% downside
Trade Information
Market Cap$197.80 billion$201.36 billion$205.11 billion$186.78 billion$222.32 billion
Beta0.430.590.840.370.7
Average Volume11,852,0091,977,7747,218,9484,024,43232,522,721
Sales & Book Value
Annual Revenue$46.84 billion$47.50 billion$33.27 billion$22.32 billion$51.75 billion
Price / Sales4.214.216.118.374.28
Cashflow$6.33 per share$7.39 per share$10.76 per share$7.44 per share$4.43 per share
Price / Cash12.3111.8210.7026.198.97
Book Value$10.21 per share$24.53 per share($5.53) per share$2.81 per share$11.46 per share
Price / Book7.643.56-20.8269.313.46
Profitability
Net Income$9.84 billion$11.73 billion$7.88 billion$8.32 billion$16.27 billion
EPS$5.19$5.24$8.94$6.04$2.95
Trailing P/E Ratio17.2528.2524.3431.8225.61
Forward P/E Ratio12.8413.399.4624.4112.97
P/E Growth1.891.761.541.572.79
Net Margins24.33%14.71%18.16%24.01%17.85%
Return on Equity (ROE)53.83%24.39%439.24%166.45%24.88%
Return on Assets (ROA)16.83%10.59%13.22%15.18%9.32%
Dividend
Annual Payout$2.60$2.08$5.20$3.40$1.56
Dividend Yield3.34%2.38%4.52%1.75%3.93%
Three-Year Dividend Growth31.22%13.60%84.37%42.31%-10.94%
Payout Ratio50.10%39.69%58.17%56.29%52.88%
Years of Consecutive Dividend Growth1 Years1 Years49 Years1 Years1 Years
Debt
Debt-to-Equity Ratio0.90%0.49%5.38%3.27%0.76%
Current Ratio1.30%0.91%0.95%1.36%1.40%
Quick Ratio1.00%0.69%0.81%1.06%1.13%
Ownership Information
Institutional Ownership Percentage72.86%9.86%67.49%75.59%67.36%
Insider Ownership Percentage0.28%0.01%0.09%0.09%0.08%
Miscellaneous
Employees73,000105,79447,00035,00078,500
Shares Outstanding2.53 billion2.29 billion1.76 billion959.03 million5.58 billion
Next Earnings Date7/30/2021 (Estimated)7/20/2021 (Estimated)7/30/2021 (Estimated)7/29/2021 (Estimated)7/27/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Pfizer (NYSE:PFE) Given New $43.00 Price Target at SVB LeerinkPfizer (NYSE:PFE) Given New $43.00 Price Target at SVB Leerink
marketbeat.com - May 11 at 8:49 AM
Pfizer shot expands to US children as young as 12 - Roanoke TimesPfizer shot expands to US children as young as 12 - Roanoke Times
roanoke.com - May 11 at 12:39 AM
PRESS DIGEST-British Business - May 11PRESS DIGEST-British Business - May 11
finance.yahoo.com - May 11 at 12:39 AM
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in AdolescentsPfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
finance.yahoo.com - May 11 at 12:39 AM
Pfizer-BioNTech COVID-19 Vaccine Gets FDA Emergency Approval For Age Group 12-15Pfizer-BioNTech COVID-19 Vaccine Gets FDA Emergency Approval For Age Group 12-15
benzinga.com - May 10 at 9:59 PM
Australia to reveal big-spending plan for next fiscal year Australia to reveal big-spending plan for next fiscal year
marketbeat.com - May 10 at 8:42 PM
‘It’s a big deal’ for Americas push to reopen, says NIH Director on Pfizer vaccine approval for adolescents‘It’s a big deal’ for America's push to reopen, says NIH Director on Pfizer vaccine approval for adolescents
cnbc.com - May 10 at 8:11 PM
Kids who take Pfizer COVID vaccine will help herd immunity - Los Angeles TimesKids who take Pfizer COVID vaccine will help herd immunity - Los Angeles Times
latimes.com - May 10 at 7:39 PM
FDA expands Pfizer COVID vaccine authorization to ages 12-15 - KING5.comFDA expands Pfizer COVID vaccine authorization to ages 12-15 - KING5.com
king5.com - May 10 at 7:39 PM
FDA authorizes Pfizer COVID-19 vaccine for adolescents 12 to 15 years old - The Boston GlobeFDA authorizes Pfizer COVID-19 vaccine for adolescents 12 to 15 years old - The Boston Globe
bostonglobe.com - May 10 at 7:39 PM
FDA Permits Pfizer Vaccine For Children As Young As 12 - NPRFDA Permits Pfizer Vaccine For Children As Young As 12 - NPR
npr.org - May 10 at 7:39 PM
FDA authorizes Pfizer for 12-15-year-olds - ABC NewsFDA authorizes Pfizer for 12-15-year-olds - ABC News
abcnews.go.com - May 10 at 7:39 PM
FDA OKs Pfizer COVID-19 Vaccine For 12-15 Age Group - NPRFDA OKs Pfizer COVID-19 Vaccine For 12-15 Age Group - NPR
npr.org - May 10 at 7:39 PM
How This FDA Move Could Push Pfizer Stock Deeper Into A Winning SpreeHow This FDA Move Could Push Pfizer Stock Deeper Into A Winning Spree
finance.yahoo.com - May 10 at 7:39 PM
FDA Authorizes Emergency Use Of Pfizers Covid-19 Vaccine For Use In Children 12 To 15 FDA Authorizes Emergency Use Of Pfizer's Covid-19 Vaccine For Use In Children 12 To 15
rttnews.com - May 10 at 7:34 PM
Pfizer-BioNTech Covid Shot Gains U.S. Clearance for Young TeensPfizer-BioNTech Covid Shot Gains U.S. Clearance for Young Teens
financialpost.com - May 10 at 6:16 PM
Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic | FDA - FDA.govCoronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic | FDA - FDA.gov
news.google.com - May 10 at 5:53 PM
FDA OKs use of Pfizer-BioNTech COVID-19 vaccine in kids ages 12 to 15FDA OKs use of Pfizer-BioNTech COVID-19 vaccine in kids ages 12 to 15
feeds.marketwatch.com - May 10 at 5:38 PM
Pfizer COVID-19 shot expanded to US children as young as 12Pfizer COVID-19 shot expanded to US children as young as 12
marketbeat.com - May 10 at 5:37 PM
FDA permits use of the Pfizer-BioNTech Covid vaccine in kids ages 12 to 15FDA permits use of the Pfizer-BioNTech Covid vaccine in kids ages 12 to 15
cnbc.com - May 10 at 5:22 PM
UKs NICE Provisionally Rejects Coverage Of Pfizer-Merck KGaAs Bavencio As First-Line Therapy For Bladder CancerUK's NICE Provisionally Rejects Coverage Of Pfizer-Merck KGaA's Bavencio As First-Line Therapy For Bladder Cancer
feeds.benzinga.com - May 10 at 3:24 PM
Pfizer Vaccines Available At Four San Diego Unified High School Campuses - KPBSPfizer Vaccines Available At Four San Diego Unified High School Campuses - KPBS
kpbs.org - May 10 at 2:38 PM
Pediatrician weighs in on Pfizer vaccine for young teens - KOBPediatrician weighs in on Pfizer vaccine for young teens - KOB
kob.com - May 10 at 2:38 PM
Pfizer, Moderna or J&J? An Expert Answers Your Questions - HealthDay NewsPfizer, Moderna or J&J? An Expert Answers Your Questions - HealthDay News
consumer.healthday.com - May 10 at 2:38 PM
Pfizer first to seek full approval for COVID-19 vaccine in US - The Daily News OnlinePfizer first to seek full approval for COVID-19 vaccine in US - The Daily News Online
thedailynewsonline.com - May 10 at 2:38 PM
Coronavirus Update: India’s COVID crisis deepens, as BioNTech says there’s no evidence its vaccine needs adapting to cope with new variantsCoronavirus Update: India’s COVID crisis deepens, as BioNTech says there’s no evidence its vaccine needs adapting to cope with new variants
marketwatch.com - May 10 at 11:58 AM
: EU won’t renew AstraZeneca COVID-19 vaccine; Pfizer shot will take precedence: EU won’t renew AstraZeneca COVID-19 vaccine; Pfizer shot will take precedence
marketwatch.com - May 10 at 11:58 AM
Sector Gamma As Buys Pfizer Inc, Baxter International Inc, Centene Corp, Sells Abbott ...Sector Gamma As Buys Pfizer Inc, Baxter International Inc, Centene Corp, Sells Abbott ...
gurufocus.com - May 10 at 11:42 AM
The Latest: Japan to purchase antibody cocktail for COVID-19The Latest: Japan to purchase antibody cocktail for COVID-19
marketbeat.com - May 10 at 11:17 AM
Vaccine maker BioNTech says no need to waive patentsVaccine maker BioNTech says no need to waive patents
marketbeat.com - May 10 at 10:19 AM
COVID-vaccine maker BioNTech reports $1.37B profit in Q1COVID-vaccine maker BioNTech reports $1.37B profit in Q1
marketbeat.com - May 10 at 8:08 AM
EU seals deal with Pfizer-BioNTech for potential 1.8 billion COVID-19 doses in its biggest vaccine contract so far.EU seals deal with Pfizer-BioNTech for potential 1.8 billion COVID-19 doses in its biggest vaccine contract so far.
marketbeat.com - May 8 at 6:13 AM
EU agrees potential 1.8 billion-dose purchase of Pfizer jabEU agrees potential 1.8 billion-dose purchase of Pfizer jab
marketbeat.com - May 8 at 6:13 AM
Asian shares mostly rise on US rally; eyes on jobs dataAsian shares mostly rise on US rally; eyes on jobs data
marketbeat.com - May 7 at 2:59 AM
The Latest: Pfizer to donate vaccines for Olympic athletes The Latest: Pfizer to donate vaccines for Olympic athletes
marketbeat.com - May 6 at 8:18 AM
Pfizer (NYSE:PFE) Rating Lowered to Neutral at MizuhoPfizer (NYSE:PFE) Rating Lowered to Neutral at Mizuho
marketbeat.com - May 6 at 7:15 AM
The Latest: Fiji locks down hospital over coronavirus deathThe Latest: Fiji locks down hospital over coronavirus death
marketbeat.com - May 5 at 10:36 PM
The Latest: Philippines to give back donated Chinese vaccineThe Latest: Philippines to give back donated Chinese vaccine
marketbeat.com - May 5 at 9:15 PM
The Latest: Chicago plans events for fully vaccinated peopleThe Latest: Chicago plans events for fully vaccinated people
marketbeat.com - May 5 at 4:57 PM
The Latest: Spain detects 11 cases of variant found in IndiaThe Latest: Spain detects 11 cases of variant found in India
marketbeat.com - May 5 at 3:23 PM
The Latest: Outreach to neighborhoods, homeless for vaccinesThe Latest: Outreach to neighborhoods, homeless for vaccines
marketbeat.com - May 5 at 2:18 PM
The Latest: Canada OKs Pfizer vaccine for ages 12 and olderThe Latest: Canada OKs Pfizer vaccine for ages 12 and older
marketbeat.com - May 5 at 10:44 AM
Pfizers posts $4.9B 1Q profit as vaccine strategy pays offPfizer's posts $4.9B 1Q profit as vaccine strategy pays off
marketbeat.com - May 4 at 4:45 PM
Pfizers long range vaccine pursuits pay offPfizer's long range vaccine pursuits pay off
marketbeat.com - May 4 at 3:23 PM
The Latest: South Africa gets first doses of Pfizer vaccineThe Latest: South Africa gets first doses of Pfizer vaccine
marketbeat.com - May 3 at 12:19 PM
EU drug regulator evaluating Pfizer vaccine for youngstersEU drug regulator evaluating Pfizer vaccine for youngsters
marketbeat.com - May 3 at 9:10 AM
The Latest: Colo. governor extends statewide mask mandateThe Latest: Colo. governor extends statewide mask mandate
marketbeat.com - May 2 at 8:49 PM
The Latest: UK increases aid to Indias health care systemThe Latest: UK increases aid to India's health care system
marketbeat.com - May 2 at 1:13 PM
The Latest: Pakistan restricts border travel to fight virusThe Latest: Pakistan restricts border travel to fight virus
marketbeat.com - May 2 at 10:53 AM
The Latest: India opens vaccination to all adults amid surgeThe Latest: India opens vaccination to all adults amid surge
marketbeat.com - May 1 at 3:18 PM
DateCompanyBrokerageAction
5/6/2021Merck & Co., Inc.SVB LeerinkLower Price Target
2/5/2021Merck & Co., Inc.Cantor FitzgeraldReiterated Rating
12/6/2020Merck & Co., Inc.MizuhoReiterated Rating
11/10/2020Merck & Co., Inc.Sanford C. BernsteinReiterated Rating
10/23/2020Merck & Co., Inc.TruistInitiated Coverage
10/16/2020Merck & Co., Inc.JPMorgan Chase & Co.Boost Price Target
9/29/2020Merck & Co., Inc.Berenberg BankInitiated Coverage
8/4/2020Merck & Co., Inc.Royal Bank of CanadaReiterated Rating
8/3/2020Merck & Co., Inc.The Goldman Sachs GroupUpgrade
6/23/2020Merck & Co., Inc.Morgan StanleyReiterated Rating
6/12/2020Merck & Co., Inc.Wolfe ResearchDowngrade
5/4/2020Merck & Co., Inc.Credit Suisse GroupReiterated Rating
4/29/2020Merck & Co., Inc.GuggenheimLower Price Target
4/29/2020Merck & Co., Inc.BarclaysLower Price Target
4/13/2020Merck & Co., Inc.UBS GroupLower Price Target
3/24/2020Merck & Co., Inc.ArgusLower Price Target
4/28/2021NovartisOddo BhfUpgrade
3/23/2021NovartisSociete GeneraleReiterated Rating
2/1/2021NovartisCowenDowngrade
1/15/2021NovartisDeutsche Bank AktiengesellschaftInitiated Coverage
6/15/2020NovartisCitigroupUpgrade
5/10/2021AbbVieBMO Capital MarketsBoost Price Target
4/30/2021AbbViePiper SandlerBoost Price Target
3/22/2021Eli Lilly andTruist SecuritiesBoost Price Target
1/22/2021Eli Lilly andBank of AmericaBoost Price Target
2/3/2021PfizerDZ BankReiterated Rating
(Data available from 5/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.